The prevalence of Metabolic-associated fatty liver disease (MAFLD) has been steadily
increasing worldwide, paralleling the global epidemic of obesity and diabetes. It is estimated …

NLR inflammasomes, caspase 1 activation platforms critical for processing key pro-
inflammatory cytokines, have been implicated in the development of nonalcoholic fatty liver …

NACHT-LRR-PYD-containing proteins 3 (NLRP3) inflammasome regulates the maturation
and secretion of proinflammatory cytokines including interleukin-1β and interleukin-18, as …

The prevalence of nonalcoholic fatty liver disease (NAFLD) is high and increasing
throughout the world. The intense sterile inflammation stemming from steatosis plays a …

Aims Identification of the progress of non-alcoholic fatty liver disease (NAFLD) is crucial for
their effective treatment. Circulating peripheral blood mononuclear cells (PBMC) could be a …

Nonalcoholic fatty liver disease (NAFLD) has been recognized as a major public health
problem worldwide. Nonalcoholic steatohepatitis (NASH) is an advanced form of NAFLD …

Background and aim Both chronic hepatitis B (CHB) and non-alcoholic fatty liver disease
(NAFLD)/non-alcoholic steatohepatitis (NASH) are the most common liver diseases over the …

Aim To examine the role of nucleotide binding oligomerization domain‐like receptor family
pyrin domain‐containing 3 (NLRP3) inflammasomes in the development of non‐alcoholic …

The activation of NOD-like receptor family pyrin domain containing 3 (NLRP3)
inflammasome is closely associated with the development and progression of non-alcoholic …

Non-alcoholic fatty liver disease (NAFLD) is among the most prevalent primary liver
diseases worldwide and can develop into various conditions, ranging from simple steatosis …